首页 | 本学科首页   官方微博 | 高级检索  
     


Vitamin D3 and insulin combined treatment promotes titanium implant osseointegration in diabetes mellitus rats
Authors:Ying-ying Wu  Tao Yu  Xiao-yong Yang  Feng Li  Li Ma  Yang Yang  Xiao-guang Liu  Yong-yue Wang  Ping Gong
Affiliation:1. State Key Laboratory of Oral Disease, Sichuan University, No. 14, Sec. 3, Renminnan Road, Chengdu 610041, Sichuan, People''s Republic of China;2. Department of Implantology, West China School of Stomatology, Sichuan University, No. 14, Sec. 3, Renminnan Road, Chengdu 610041, Sichuan, People''s Republic of China;3. Department of Head and Neck Oncology, Sichuan Cancer Hospital, No. 55, Sec. 4, Renminnan Road, Chengdu 610041, Sichuan, People''s Republic of China;4. Department of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, Huanhuxi Road, Hexi District, Tianjin 300060, People''s Republic of China;5. Department of Biomaterials Center, Sichuan University, No. 24, Sec. 1, Yihuan Road, Chengdu 610065, Sichuan, People''s Republic of China
Abstract:This study investigated the effect of insulin and vitamin D3 (VD3) treatment on implant osseointegration in diabetic mellitus (DM) rats. DM was induced by administration of streptozotocin in rats, which received implants insertion in the femur. Then animals were subjected to different treatment and divided to the following group: control, diabetic, insulin-treated diabetic, VD3-treated diabetic, insulin and VD3 combination-treated diabetic rats. The glucose levels and weight of rats were periodically evaluated, and serum 25(OH)D3 levels in rats were measured at the end of the experiment. Animals were sacrificed at 12 weeks after surgery, the peri-implant trabecular microstructure, implant fixation and implant osseointegration were measured by microscopic computerized tomography (micro-CT) evaluation, push-out test and histomorphometric analysis. Diabetic rats displayed significantly higher blood glucose level, lower body weight, lower serum 25(OH)D3 levels, and less implant osseointegration than controls. Insulin treatment showed restorative effect on body weight and serum 25(OH)D3 levels of diabetic rats, but the blood glucose level in diabetic rats were still substantially higher compared to controls after 14 days therapy of insulin. Combined treatment restored hyperglycemia in diabetic rats to be normal, and reversed the impaired osseointegration capacity of implants, with the bone volume ratio and percent osseointegration increased by 1.37-fold and 1.6-fold in micro-CT evaluation, the maximal push-out force and ultimate shear strength by 1.3-fold and 2.1-fold in push-out test, and the bone-to-implant contact and bone area ratio increased by 2.57-fold and 1.44-fold in histomorphometric analysis. Monotreatment also enhanced implant fixation, but less. These results indicated that insulin and VD3 combined treatment may be an effective approach to enhance implant fixation in diabetic rats, but whether the results could be extrapolated to human needs further study.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号